Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 8, 2021

Primary Completion Date

December 3, 2021

Study Completion Date

January 3, 2022

Conditions

Acute GastroenteritisAbdominal Pain

Interventions

DRUG

Hyoscine N Butylbromide

Hyoscine N butylbromide injection for the treatment of abdominal pain in acute gastroenteritis

OTHER

Placebo

2 ml of normal saline injection as placebo

Trial Locations (1)

Ankara City Hospital, Ankara

All Listed Sponsors

lead

Ankara City Hospital Bilkent

OTHER

NCT04682860 - Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide | Biotech Hunter | Biotech Hunter